Clinical Trial Update: Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares lerisetron with granisetron to prevent nausea and vomiting in men undergoing radiation therapy for stage I seminoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seminoma
• Testicular Germ Cell Tumor

Drugs mentioned

• Granisetron (granisetron)
• Lerisetron (lerisetron)

Snippet

Sponsor: Simbec Research | Conditions: Nausea and Vomiting, Testicular Germ Cell Tumor | Phase 3 | Status: UNKNOWN